166 related articles for article (PubMed ID: 33326107)
1. Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma.
Pascoal S; Grissenberger S; Scheuringer E; Fior R; Ferreira MG; Distel M
Methods Mol Biol; 2021; 2226():243-255. PubMed ID: 33326107
[TBL] [Abstract][Full Text] [Related]
2. Genetically Engineered Mouse Model in Ewing Sarcoma.
Tanaka M; Nakamura T
Methods Mol Biol; 2021; 2226():183-189. PubMed ID: 33326102
[TBL] [Abstract][Full Text] [Related]
3. Tumor Growth Analysis of Ewing Sarcoma Cell Lines Using Subcutaneous Xenografts in Mice.
Cidre-Aranaz F; Ohmura S
Methods Mol Biol; 2021; 2226():191-199. PubMed ID: 33326103
[TBL] [Abstract][Full Text] [Related]
4. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM
PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320
[TBL] [Abstract][Full Text] [Related]
5. Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts.
López-Alemany R; Tirado OM
Methods Mol Biol; 2021; 2226():201-213. PubMed ID: 33326104
[TBL] [Abstract][Full Text] [Related]
6. Ewing Sarcoma PDX Models.
Surdez D; Landuzzi L; Scotlandi K; Manara MC
Methods Mol Biol; 2021; 2226():223-242. PubMed ID: 33326106
[TBL] [Abstract][Full Text] [Related]
7. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE
J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828
[TBL] [Abstract][Full Text] [Related]
8. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD
Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745
[TBL] [Abstract][Full Text] [Related]
9. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
10. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
[TBL] [Abstract][Full Text] [Related]
11. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
12. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.
Hesketh AJ; Maloney C; Behr CA; Edelman MC; Glick RD; Al-Abed Y; Symons M; Soffer SZ; Steinberg BM
PLoS One; 2015; 10(12):e0145197. PubMed ID: 26709919
[TBL] [Abstract][Full Text] [Related]
13. Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenograft Model.
Giner F; López-Guerrero JA; Fernández-Serra A; Machado I; Mayordomo-Aranda E; Peydró-Olaya A; Llombart-Bosch A
Pediatr Dev Pathol; 2019; 22(1):30-39. PubMed ID: 29895220
[TBL] [Abstract][Full Text] [Related]
14. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
15. Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging.
Liebsch L; Kailayangiri S; Beck L; Altvater B; Koch R; Dierkes C; Hotfilder M; Nagelmann N; Faber C; Kooijman H; Ring J; Vieth V; Rossig C
Br J Cancer; 2013 Aug; 109(3):658-66. PubMed ID: 23839490
[TBL] [Abstract][Full Text] [Related]
16. Discovering novel oncogenic pathways and new therapies using zebrafish models of sarcoma.
Hayes MN; Langenau DM
Methods Cell Biol; 2017; 138():525-561. PubMed ID: 28129857
[TBL] [Abstract][Full Text] [Related]
17. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
[TBL] [Abstract][Full Text] [Related]
18. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
[TBL] [Abstract][Full Text] [Related]
19. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
20. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
